Lifecore Biomedical, Inc. De (LFCR) Price to Book (2011 - 2025)

Lifecore Biomedical has reported Price to Book for 15 years, with the latest figure at 186.24 in Q2 2025.

• On a quarterly basis, Price to Book rose 1126.86% year-over-year to 186.24 in Q2 2025; TTM through May 2025 was 186.24, a 1126.86% increase from a year earlier, with the FY2025 full-year figure at 186.24, up 5321.39% from the prior year.
• Price to Book was 186.24 for Q2 2025 at Lifecore Biomedical, up from 93.52 in the prior quarter.
• The five-year high for Price to Book was 186.24 in Q2 2025, with the low at 56.92 in Q2 2023.
• Average Price to Book over 5 years is 24.38, with a median of 3.44 recorded in 2022.
• The largest YoY upside for Price to Book was 4416.15% in 2023 against a maximum downside of 1815.99% in 2023.
• Over 5 years, Price to Book stood at 1.64 in 2021, then soared by 116.75% to 3.56 in 2022, then soared by 4416.15% to 160.98 in 2023, then tumbled by 89.13% to 17.5 in 2024, then jumped by 964.34% to 186.24 in 2025.
• The last three Price to Book figures came in at 186.24 (Q2 2025), 93.52 (Q1 2025), and 17.5 (Q4 2024), per Business Quant data.